Safety and Adherence to Intermittent Pre-Exposure Prophylaxis (PrEP) for HIV-1 in African Men Who Have Sex with Men and Female Sex Workers

• Gaudensia Mutua ,

  Contributed equally to this work with: Gaudensia Mutua, Eduard Sanders

  Affiliation Kenya AIDS Vaccine Initiative, University of Nairobi, Nairobi, Kenya

  ⨯
• Eduard Sanders ,

  Contributed equally to this work with: Gaudensia Mutua, Eduard Sanders

  Affiliations Kenya Medical Research Institute, Kilifi, Kenya, Nuffield Department of Medicine, University of Oxford, Headington, United Kingdom

  ⨯
• Peter Mugo,

  Affiliation Kenya Medical Research Institute, Kilifi, Kenya

  ⨯
• Omu Anzala,

  Affiliation Kenya AIDS Vaccine Initiative, University of Nairobi, Nairobi, Kenya

  ⨯
• Jessica E. Haberer,

  Affiliation Massachusetts General Hospital Center for Global Health, Boston, Massachusetts, United States of America

  ⨯
• David Bangsberg,

  Affiliation Massachusetts General Hospital Center for Global Health, Boston, Massachusetts, United States of America

  ⨯
• Burc Barin,

  Affiliation The EMMES Corporation, Rockville, Maryland, United States of America

  ⨯
• James F. Rooney,

  Affiliation Gilead, Foster City, California, United States of America

  ⨯
• David Mark,

  Affiliation International AIDS Vaccine Initiative, New York, New York, United States of America

  ⨯
• Paramesh Chetty,

  Affiliation International AIDS Vaccine Initiative, Johannesburg, South Africa

  ⨯
• Patricia Fast,

  Affiliation International AIDS Vaccine Initiative, New York, New York, United States of America

  ⨯
• Frances H. Priddy

  * E-mail: fpriddy@iavi.org

  Affiliation International AIDS Vaccine Initiative, New York, New York, United States of America

  ⨯